Hostname: page-component-7b7567c8c-lpg2g Total loading time: 0 Render date: 2026-11-15T14:39:29.445Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacogenetics and mental disease

Published online by Cambridge University Press:  09 July 2009

Gilbert S. Omenn and
Arno G. Motulsky
Gilbert S. Omenn
Affiliation:
The work was supported by grant GM 15253 and a Research Development Award (G.S.O.) from the U.S. Public Health Service.
Arno G. Motulsky
Affiliation:
The work was supported by grant GM 15253 and a Research Development Award (G.S.O.) from the U.S. Public Health Service.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Editorial
Information
Psychological Medicine , Volume 4 , Issue 2 , May 1974, pp. 125 - 129
Copyright
Copyright © Cambridge University Press 1974

References

REFERENCES

Alexanderson, B., and Sjöqvist, F. (1971). Individual differences in the pharmacokinetics of monomethylated tri-cyclic antidepressants: role of the genetic and environmental factors and clinical importance. Annals of the New York Academy of Sciences, 179, 739–751.CrossRefGoogle Scholar
Angrist, B. M., Shopsin, B., and Gershon, S. (1971). The comparative psychotomimetic effects of stereoisomers of amphetamine. Nature, 234, 152–153.CrossRefGoogle ScholarPubMed
Angst, J. (1964). Antidepressiver Effekt and genetische Faktoren. Arzneimittelforschung, 14, Suppl. 496–500.Google Scholar
Cohen, S. N., and Weber, W. W. (1972). Pharmacogenetics. Pediatric Clinics of North America, 19, 21–36.CrossRefGoogle ScholarPubMed
Evans, D. A. P. (1969). Pharmacogenetics. In Selected Topics in Medical Genetics, pp. 69–109. Edited by Clarke, C. A.. Oxford University Press: London.Google Scholar
Evans, D. A. P., Davison, K., and Pratt, R. T. C. (1965). The influence of acetylator phenotype on the effects of treating depression with phenelzine. Clinical Pharmacology and Therapeutics, 6, 430–435.CrossRefGoogle ScholarPubMed
Fenna, D., Mix, L., Schaefer, O., and Gilbert, J. A. L. (1971). Ethanol metabolism in various racial groups. Canadian Medical Association Journal, 105, 472–475.Google ScholarPubMed
Gershon, E. S., Dunner, D. L., and Goodwin, F. K. (1971). Toward a biology of affective disorders. Genetic contributions. Archives of General Psychiatry, 25, 1–15.CrossRefGoogle Scholar
Harris, T. H. (1957). Depression induced by Rauwolfia compounds. American Journal of Psychiatry, 113, 950.Google ScholarPubMed
Hollister, L. E. (1970). Choice of antipsychotic drugs. American Journal of Psychiatry, 127, 186–190.CrossRefGoogle ScholarPubMed
Horn, A. S., and Snyder, S. H. (1971). Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proceedings of the National Academy of Sciences, 68, 2325–2328.CrossRefGoogle ScholarPubMed
Johnstone, E. C., and Marsh, W. (1973). Acetylator status and response to phenelzine in depressed patients. Lancet, 1, 567–570.CrossRefGoogle ScholarPubMed
Jones, K. L., Smith, D. W., Ulleland, C. N., and Streissguth, A. P. (1973). Pattern of malformation in offspring of chronic alcoholic mothers. Lancet, 1, 1267–1271.CrossRefGoogle ScholarPubMed
Kalow, W. (1962). Pharmacogenetics: Heredity and the Response to Drugs. Saunders: Philadelphia.Google Scholar
Klawans, H. L. Jr, Paulson, G. W., Ringel, S. P., and Barbeau, A. (1972). Use of L-dopa in the detection of pre-symptomatic Huntington's chorea. New England Journal of Medicine, 286, 1332–1334.CrossRefGoogle Scholar
Kutt, H. (1971). Biochemical and genetic factors regulating Dilantin metabolism in man. Annals of the New York Academy of Sciences, 179, 705–722.CrossRefGoogle ScholarPubMed
Morrow, A. C., and Motulsky, A. G. (1968). Rapid screening method for the common atypical pseudocholinesterase variant. Journal of Laboratory and Clinical Medicine, 71, 350–356.Google Scholar
Motulsky, A. G. (1972). Hemolysis in glucose-6-phosphate dehydrogenase deficiency. Federation Proceedings, 31, 1286–1292.Google ScholarPubMed
Motulsky, A. G. (1964). Pharmacogenetics. Progress in Medical Genetics, 3, 49–74.Google Scholar
Musacchio, J. M., Julou, L., Kety, S. S., and Glowinski, S. S. (1969). Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proceedings of the National Academy of Sciences, 63, 1117–1119.CrossRefGoogle ScholarPubMed
Myrianthopoulos, N. C., Waldrop, F. N., and Vincent, B. L. (1969). A repeat study of hereditary predisposition in drug-induced parkinsonism. In Progress in Neuro-Genetics. Edited by Barbeau, A. and Brunette, J.-R.. Excerpta Medica: Amsterdam. International Congress Series No. 175, 486–491.Google Scholar
Omenn, G. S. (1973a). Genetic issues in the syndrome of minimal brain dysfunction. Seminars in Psychiatry, 5, 5–17.Google ScholarPubMed
Omenn, G. S. (1973b). A pharmacogenetic approach to depression, in Bruell, J. (ed.), Prospects in Behavior Genetics. Russell Sage Foundation: New York. (In press.)Google Scholar
Omenn, G. S., and Motulsky, A. G. (1972). A biochemical and genetic approach to alcoholism. Annals of the New York Academy of Sciences, 197, 16–23.CrossRefGoogle ScholarPubMed
Omenn, G. S., and Motulsky, A. G. (1973). Pharmacogenetics. Year Book of Drug Therapy, 1973, pp. 5–26. Year Book Medical Publishers: Chicago.Google Scholar
Pare, C. M. B., and Mack, J. W. (1971). Differentiation of two ganetically specific types of depression by the response to antidepressant drugs. Journal of Medical Genetics, 8, 306–309.CrossRefGoogle ScholarPubMed
Pare, C. M. B., Rees, L., and Sainsbury, M. J. (1962). Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet, 2, 1340–1343.CrossRefGoogle ScholarPubMed
Rosenthal, D. (1970). Genetic Theory and Abnormal Behavior, pp. 92–200. McGraw-Hill: New York.Google Scholar
Schildkraut, J. J. (1969). Neuropsychopharmacology and the affective disorders. New England Journal of Medicine, 281, 197–201, 248–255, 302–308.CrossRefGoogle ScholarPubMed
Schuckit, M. A. (1972). Family history and half-sibling research in alcoholism. Annals of the New York Academy of Sciences, 197, 121–125.CrossRefGoogle ScholarPubMed
Snyder, S. H., Taylor, K. M., Coyle, J. T., and Meyerhoff, J. L. (1970). The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. American Journal of Psychiatry, 127, 199–207.CrossRefGoogle ScholarPubMed
Vesell, E. S., Page, J. G., and Passananti, G. T. (1971). Genetic and environmental factors affecting ethanol metabolism in man. Clinical Pharmacology and Therapeutics, 12, 192–201.CrossRefGoogle ScholarPubMed
Vogel, F. (1970). The genetic basis of the normal human electroencephalogram (EEG). Humangenetik, 10, 91–114.CrossRefGoogle ScholarPubMed
Watson, C. J., Dhar, G. J., Bossenmaier, I., Cardinal, R., and Petryka, Z. J. (1973). Effect of hematin in acute porphyric relapse. Annals of Internal Medicine, 79, 80–83.CrossRefGoogle ScholarPubMed
Williams, R. J. (1956). Biochemical Individuality. Wiley: New York.Google Scholar
Wolff, P. H. (1972). Ethnic differences in alcohol sensitivity. Science, 175, 449–450.CrossRefGoogle ScholarPubMed